MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome

Mucin 1 (MUC1) is a novel partner for MAL2 in breast carcinoma cells

(2009) Susan Fanayan et al.   BMC CELL BIOLOGY

Copy Number Alterations that Predict Metastatic Capability of Human Breast Cancer

(2009) Y. Zhang et al.   CANCER RESEARCH

PPM1D Is a Potential Therapeutic Target in Ovarian Clear Cell Carcinomas

(2009) D. S.P. Tan et al.   CLINICAL CANCER RESEARCH

Differential Protein Mapping of Ovarian Serous Adenocarcinomas: Identification of Potential Markers for Distinct Tumor Stage

(2009) Yanfei Wang et al.   JOURNAL OF PROTEOME RESEARCH

Linking the ovarian cancer transcriptome and immunome

(2008) Ronald Rapberger et al.   BMC Systems Biology

Immortalization and transformation of human mammary epithelial cells by a tumor-derived Myc mutant

(2008) Clare A. Thibodeaux et al.   BREAST CANCER RESEARCH AND TREATMENT

β 2 microglobulin mRNA expression levels are prognostic for lymph node metastasis in colorectal cancer patients

(2008) J Shrout et al.   BRITISH JOURNAL OF CANCER

Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome

(2008) R. W. Tothill et al.   CLINICAL CANCER RESEARCH

Nonredundant Functions for Tumor Protein D52-Like Proteins Support Specific Targeting of TPD52

(2008) M. Shehata et al.   CLINICAL CANCER RESEARCH

Global Gene Expression Profiling Unveils S100A8/A9 as Candidate Markers in H-Ras-Mediated Human Breast Epithelial Cell Invasion

(2008) A. Moon et al.   MOLECULAR CANCER RESEARCH